Assenagon Asset Management
CERE

Assenagon Asset Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Assenagon Asset Management’s Portfolio CERE Stock Details CERE Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-299,891
Closed -$12.7M – 1462
2023
Q4 		$12.7M Buy
+299,891
New +$12.7M 0.03% 369